Yw. Tang et al., COMPARATIVE-EVALUATION OF COLORIMETRIC MICROTITER PLATE SYSTEMS FOR DETECTION OF HERPES-SIMPLEX VIRUS IN CEREBROSPINAL-FLUID, Journal of clinical microbiology, 36(9), 1998, pp. 2714-2717
In the past few years, application of the PCR to the detection of herp
es simplex virus (HSV) DNA in the cerebrospinal fluid (CSF) from patie
nts with encephalitis and meningitis has become standard laboratory pr
actice. However, from an operational perspective, the true diagnostic
value of PCR in this setting is yet to be realized because most labora
tories subject the amplification products to lengthy probe hybridizati
on procedures by Southern blotting. As alternatives to Southern blotti
ng, we evaluated colorimetric microtiter plate (MTP) systems from Viro
Med Laboratories, Inc, (PrimeCapture), CPG, Inc. (Quanti-PATH), and In
c-star Corp. (GEN-ETI-K), in addition to a system developed at the May
o Clinic with the PCR ELISA system (Boehringer Mannheim Corp,). We tes
ted PCR products from 86 clinical CSF specimens submitted to our Molec
ular Microbiology Laboratory. The CSF specimens used had to have suffi
cient volume for comparative analysis. By conventional Southern blotti
ng methods, 54 were positive and 32 were negative for HSV DNA. Compare
d with Southern blotting, the sensitivity and specificity were 63.0 an
d 100.0%, respectively, for the PrimeCapture system, 98.2 and 96.9%, r
espectively, for the Quanti-PATH system, 95.2 and 100.0%, respectively
, for the GEN-ETI-K system, and 100.0 and 96.9%;, respectively, for th
e Mayo system. All four MTP systems had turnaround times 12 to 24 h le
ss than that for Southern blotting. There were no significant differen
ces in costs or technologist time between the Mayo system and Southern
blotting, Other features of the Mayo system include type-specific gen
otypic identification of HSV and the potential for determination of dr
ug resistance by DNA sequencing. Overall, we found that colorimetric M
TP systems were likely to improve test turnaround times and patient ca
re at no additional cost.